Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2011
10/27/2011WO2011130878A1 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
10/27/2011WO2011130817A1 Pharmaceutical formulation and method for reducing hepatotoxicity
10/27/2011WO2011130799A1 Pharmaceutical compositions
10/27/2011WO2011130798A1 Cold treatment
10/27/2011WO2011092593A3 Hiv-1 neutralizing antibodies and uses thereof
10/27/2011WO2011069227A8 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/27/2011WO2011060390A3 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
10/27/2011WO2011057160A3 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
10/27/2011WO2011047319A8 Antimicrobial compounds and methods of making and using the same
10/27/2011WO2010119365A3 A medicinal cream made using clotrimazole and chitosan and a process to make the same
10/27/2011US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011US20110263698 Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof
10/27/2011US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011US20110263683 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
10/27/2011US20110263680 Reduced size self-delivering rnai compounds
10/27/2011US20110263668 Beta 3-Adrenoreceptor Agonists for the Treatment of Cardiac Hypertrophy and Heart Failure
10/27/2011US20110263665 Formulations comprising an anti-microbial composition
10/27/2011US20110263646 Pharmaceutical topical compositions
10/27/2011US20110263625 Hiv replication inhibiting pyrimidines
10/27/2011US20110263620 Quinoline compounds and their use for treating viral infection
10/27/2011US20110263614 Novel compounds
10/27/2011US20110263590 Antibacterial Compositions
10/27/2011US20110263587 Reversibly heat-gelable aqueous composition
10/27/2011US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011US20110263565 Compounds
10/27/2011US20110263554 Screen for inhibitors of filovirus and uses therefor
10/27/2011US20110263551 Method for treating otitis externa
10/27/2011US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011US20110263548 Pyridone and pyridazone analogues as gpr119 modulators
10/27/2011US20110263536 Methods of Treating Orthopox Virus Infections and Associated Diseases
10/27/2011US20110263535 Tyrosine-based prodrugs of antiviral agents
10/27/2011US20110263534 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
10/27/2011US20110263528 Antimicrobial compositions
10/27/2011US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011US20110263492 Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension of dispersion media
10/27/2011US20110263486 Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation
10/27/2011US20110263485 Bifunctional Griffithsin Analogs
10/27/2011US20110263484 Single chain fc type iii interferons and methods of using same
10/27/2011US20110262565 PIP-2 Inhibition-Based Antiviral and Anti-Hyperlipidemic Therapies
10/27/2011US20110262558 Composition For Skin Sanitization And Protection And Method Of Its Use
10/27/2011US20110262556 Silver/water, silver gels and silver-based compositions; and methods for making and using the same
10/27/2011US20110262550 Method for treating a skin ailment
10/27/2011US20110262542 Controlled Delivery of Tetracycline Compounds and Tetracycline Derivatives
10/27/2011US20110262533 Pharmaceutical formulation for use in hiv therapy
10/27/2011US20110262529 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/27/2011US20110262527 Cationic lipids and methods of use
10/27/2011US20110262526 Method of inducing an anti-viral immune response
10/27/2011US20110262511 Novel Uses
10/27/2011US20110262508 Antimicrobial compositions, formulations and uses thereof
10/27/2011US20110262506 Topical compositions containing coated active agents
10/27/2011US20110262503 Flowable Wound Matrix and its Preparation and Use
10/27/2011US20110262502 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
10/27/2011US20110262488 Novel HIV-1 Envelope Glycoprotein
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011US20110262484 Outer membrane vesicle prime-protein boost vaccine
10/27/2011US20110262483 Methods for isolating enveloped virus-based vlps free of infectious agents
10/27/2011US20110262482 Anti-viral compounds
10/27/2011US20110262481 High growth reassortant influenza a virus
10/27/2011US20110262480 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method
10/27/2011US20110262478 Recombinant Protein Bodies as Immunogen-Specific Adjuvants
10/27/2011US20110262477 Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
10/27/2011US20110262476 Mutant bacterial glycoproteins and uses thereof
10/27/2011US20110262475 Lyme disease vaccine
10/27/2011US20110262474 Chimeric HIV Antigens
10/27/2011US20110262473 Synthetic vaccine component
10/27/2011US20110262472 Vaccine compositions for the treatment of dengue fever and uses thereof
10/27/2011US20110262467 Novel Artificial Antigen Presenting Cells and Uses Therefor
10/27/2011US20110262461 Biological materials and uses thereof
10/27/2011US20110262457 Modulation of the immune response
10/27/2011US20110262435 Il-13 binding agents
10/27/2011US20110262420 Inhalant comprising modified superoxide dismutase
10/27/2011US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011US20110262409 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus
10/27/2011US20110262406 Compositions and methods for targeted inactivation of hiv cell surface receptors
10/27/2011US20110262400 Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
10/27/2011US20110262397 Compounds, compositions, and methods for control of hepatitis c viral infections
10/27/2011US20110262394 Dna constructs eliciting immune response against flavivirus and effective adjuvants
10/27/2011US20110262386 Methods of treating inflammation
10/27/2011US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/27/2011US20110262378 Rifaximin Complexes
10/27/2011US20110262368 C21 thioethers as glucocorticoid receptor agonists
10/27/2011US20110262364 Fluorescent Particles Comprising Nanoscale ZnO Layer and Exhibiting Cell-Specific Toxicity
10/27/2011US20110262361 effective new drug target for the treatment of tuberculosis
10/27/2011CA2812043A1 Pyrimidinedione anti-viral compounds
10/27/2011CA2811989A1 Diarylpyridine anti-viral compounds
10/27/2011CA2796726A1 Lysine specific demethylase-1 inhibitors and their use
10/26/2011EP2380976A1 Human anti-human influenza virus antibody
10/26/2011EP2380874A2 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
10/26/2011EP2380872A1 Polycationic compounds and uses thereof
10/26/2011EP2380590A2 Improved tuberculosis vaccines
10/26/2011EP2380589A2 Improved tuberculosis vaccines
10/26/2011EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
10/26/2011EP2380565A1 Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates
10/26/2011EP2379591A1 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
10/26/2011EP2379579A1 Hcv ns3 protease inhibitors
10/26/2011EP2379549A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament
10/26/2011EP2379546A1 Monocarbams
10/26/2011EP2379545A1 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
1 ... 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 ... 1798